Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis/Reply
Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis/Reply
About this item
Full title
Author / Creator
Publisher
New York: American Thoracic Society
Journal title
Language
English
Formats
Publication information
Publisher
New York: American Thoracic Society
More information
Scope and Contents
Contents
In their per-protocol analyses they found a significant decrease in viable colony-forming unit counts of Mycobacterium tuberculosis with each 5 mg/kg increase in rifampicin dose and with each log increase in rifampicin area under the plasma concentration-time curve from 0 to 6 hours (AUC0-6), but not with each log increase in AUC0-6/minimum inhibit...
Alternative Titles
Full title
Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis/Reply
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2225229223
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2225229223
Other Identifiers
ISSN
1073-449X
E-ISSN
1535-4970
DOI
10.1164/rccm.201811-2101LE
